Imerys Talc America (ITA) Company Profile

06:01 EDT 17th October 2018 | BioPortfolio

News Articles [135 Associated News Articles listed on BioPortfolio]

J&J and Imerys Lose Mesothelioma Lawsuit

Johnson & Johnson, the US market’s largest healthcare company, and its talc supply partner Imerys Talc America have lost their first lawsuit involving the deadly cancer mesothelioma.

J&J, Imerys unit must pay $117 million in N.J. asbestos cancer case

Johnson & Johnson and Imerys Talc America, a unit of Imerys SA, must pay $117 million in damages in a case involving a man who said he developed cancer due to his exposure to asbestos in talc-base...

J&J, Imerys must pay $37 million in case over talc cancer risks: jury

(Reuters) - Johnson & Johnson and Imerys SA must pay at least $37 million in a lawsuit claiming a man developed cancer due to his exposure to asbestos in talc-based products including Johnson's Baby...

Imerys unit settles talc claims for at least $5 million: Bloomberg

(Reuters) - A unit of French minerals company Imerys SA settled claims by 22 women related to talc supplied to Johnson & Johnson for making baby powder for at least $5 million, Bloomberg reported on F...

J&J, Imerys must pay $80 mln punitive damages in case linking cancer to asbestos in talc

Johnson & Johnson and an Imerys SA unit must pay an additional $80 million in punitive damages in a lawsuit claiming a man developed cancer due to his exposure to asbestos in talc-based products, ...

Imerys Talc America Inc. (ITA) to Appeal Jury Verdict in Lanzo Trial

ITA will appeal the decision of a New Jersey jury that found it and Johnson & Johnson responsible for a New Jersey resident’s lung disease. Mr. Lanzo has mesothelioma, a for...

Johnson & Johnson, Imerys must pay $117 million to New Jersey man in asbestos cancer case

NEW YORK (Reuters) - Johnson & Johnson and a unit of Imerys SA must pay $117 million in damages to a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jers...

Johnson & Johnson, Imerys ordered to pay additional US$80mln in punitive damages in talc-cancer case

A New Jersey state court jury awarded the damages today, the report says

Drugs and Medications [665 Associated Drugs and Medications listed on BioPortfolio]

Antimicrobial [Safetec of America]


A.b.h.c. instant hand sanitizer citrus scent [Safetec of America, Inc.]


Hydrocortisone [Safetec of America, Inc.]

Safetec First Aid 1% Hydrocortisone Cream

Analgesic [Safetec of America, Inc.]

Safetec of America, Inc. PAIN SPRAY

Antiseptic [Safetec of America]

ANTISEPTIC – Benzalkonium chloride liquid Safetec of America

PubMed Articles [471 Associated PubMed Articles listed on BioPortfolio]

Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion.

Background Malignant pleural effusion affects more than 750,000 persons each year across Europe and the United States. Pleurodesis with the administration of talc in hospitalized patients is the most ...

The Hospital and Patient Burden of Indwelling Pleural Catheters: A Retrospective Case Series of 210 Indwelling Pleural Catheter Insertions.

Indwelling pleural catheters (IPC) offer an alternative to talc pleurodesis in recurrent effusion, especially in patients wishing to avoid hospitalization. Two randomized trials have demonstrated redu...

Identification of Foreign Particles in Human Tissues using Raman Microscopy.

The precise identification of foreign particles in tissue for patient care and research has been studied using polarized light microscopy, electron microscopy with X-ray analysis, and electron diffrac...

Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion.

Malignant pleural effusion (MPE) is common and imposes a significant burden on patients and health care providers. Most patients require definitive treatment, such as drainage and chemical pleurodesis...

The mineralogy and epidemiology of cosmetic talc.

Clinical Trials [384 Associated Clinical Trials listed on BioPortfolio]

Talc in Treating Patients With Malignant Pleural Effusion

RATIONALE: Talc may relieve malignant pleural effusion. It is not yet known whether wet talc is more effective than dry talc in treating patients with malignant pleural effusion. PURPOSE:...

Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management

This is a multicentre randomised controlled trial evaluating global health related quality of life outcomes in patients with malignant pleural effusions. Patients will be randomised to rec...

Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion

This is prospective randomized control trial study. The aim of this study is to evaluate the efficacy of Iodopovidone solution for pleurodesis in palliative malignant pleural effusion (MPE...

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

RATIONALE: Video-assisted surgery to remove part of the tissue layer covering the inside of the chest cavity may be effective in treating pleural effusion and cause less damage to normal t...

Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer

RATIONALE: It is not yet known whether pleurodesis using a chest tube with infusions of talc is more effective in improving quality of life than pleurodesis using a small catheter in treat...

Companies [918 Associated Companies listed on BioPortfolio]

Imerys Talc America (ITA)

Fagron North America

Fagron North America is a group of innovative, scientific pharmaceutical companies that focus on optimizing and innovating pharmaceutical compounding across the U.S. Fagron North ...

JMS North America Corporation

JMS North America (JMSNA) was established as a wholly owned subsidiary of JMS Co., Ltd., one of the largest Japanese medical device companies, in March 1993. Now JMSNA's headquarters is located in Hay...

Trilantic North America

Trilantic Capital Management L.P. ("Trilantic North America") is a private equity firm focused on control and significant minority investments in North America. Trilantic North Am...


Nichiryo America, Inc. was established in 1996 as a wholely owned subsidiary of Nichiyro Co., Ltd. Nichiryo America handles the sales, marketing and customer support for North, Central, and South Amer...

More Information about "Imerys Talc America (ITA)" on BioPortfolio

We have published hundreds of Imerys Talc America (ITA) news stories on BioPortfolio along with dozens of Imerys Talc America (ITA) Clinical Trials and PubMed Articles about Imerys Talc America (ITA) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Imerys Talc America (ITA) Companies in our database. You can also find out about relevant Imerys Talc America (ITA) Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record